Zika Virus Replication Is Substantially Inhibited by Novel Favipiravir and Interferon Alpha Combination Regimens

Zika virus (ZIKV) is a major public health concern due to its overwhelming spread into the Americas. Currently, there are neither licensed vaccines nor antiviral therapies available for the treatment of ZIKV. We aimed to identify and rationally optimize effective therapeutic regimens for ZIKV by eva...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Pires de Mello, Camilly P., Tao, Xun, Kim, Tae Hwan, Bulitta, Jürgen B., Rodriquez, Jaime L., Pomeroy, Justin J., Brown, Ashley N.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2017
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5740374/
https://ncbi.nlm.nih.gov/pubmed/29109164
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01983-17
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi